Senate, White House hoping for deal to restructure Medicare drug payments
Sens. Chuck Grassley and Ron Wyden are close to finalizing legislation that could reshape the U.S. drug reimbursement landscape. If they succeed, the Senate Finance Committee could release and vote on legislation this week or next, individuals involved in discussions at the White House and on Capitol Hill told BioCentury.
Congressional staffers are racing the clock to finalize legislation in an attempt to slide it